The CureLab Oncology team has completed its international
Phase I/IIa Clinical Trials of Elenagen.
The vaccine demonstrated a high degree of safety as well as clinical benefits in a number of patients.
Based on these successful results, we initiated Phase II Clinical Trials
outside of the
United States, and are now preparing Phase II Clinical Trials within
the US.